REFERENCES
- Futrakul N, Sila-asna M, Futrakul P. Therapeutic strategy towards renal restoration in chronic kidney disease. Asian Biomed. 2007;1:33–44.
- Futrakul N, Vongthavarawat V, Sirisalipotch S, Chairatanarat T, Futrakul P, Suwanwalaikorn S. Tubular dysfunction and hemodynamic alteration in normoalbuminutic type 2 diabetes. Clin Hemorheo Microcirc. 2005;32:57–65.
- Hohenstein B, Hansknicht B, Bochmer K, Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006;69:1654–1661.
- Futrakul N, Butthep P, Futrakul P, Sitprija V. Glomerular endothelial dysfunction in type 2 diabetes mellitus. Ren Fail. 2006;28:523–524.
- Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in type 2 diabetic nephropathy. Ren Fail. 2009;31:207–210.
- Natarajan R, Bai W, Lanting L, Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cell. Am J Physiol. 1992;273:H2224–H2231.
- Bortoloso E, Dol Prete D, Vestra MD, Quantitation and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol. 2004;150:799–807.
- Cooper ME, Vranes D, Youssef S, Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR2 in experimental diabetes. Diabetes. 1999;48:2229–2239.
- Loomans CJ, de Koning EJ, Staal FJ, Endothelial progenitor cell dysfunction a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53:195–199.
- Williams B, Baker AQ, Gallacher B, Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension. 1995;25:913–917.
- Miyauchi H, Minamino T, Tatono K, Akt negatively regulates the in vitro life span of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23:212–220.
- Nakagawa T, Sato W, Suertin YY, Uncoupling of a vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy. J Am Soc Nephrol. 2006;17:736–745.
- Li J, Bertram JF. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology. 2010;15:507–512.
- Futrakul N, Futrakul P. Vascular repair is adequately functional in early stage of diabetic nephropathy. Asian Biomed. 2010; in press.
- Futrakul P, Yenrudi S, Futrakul N, Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886–891.
- Deekajorndech T. Fractional excretion of magnesium (FE Mg) in systemic lupus erythematosus. J Med Assoc Thai. 2005;88:743–745.
- Futrakul N, Futrakul P, Siriviriyakul P. Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis. Clin Hemorheo Microcirc. 2004;31:197–205.
- Ritt M, Ott C, Raff U, Renal vascular endothelial function in hypertensivepatients with type 2 diabetes mellitus. Am J Kidney Dis. 2009;53:281–289.